Refractory dermatomyositis responsive to anifrolumab
JAAD Case Rep
.
2023 Nov 7:43:27-29.
doi: 10.1016/j.jdcr.2023.10.023.
eCollection 2024 Jan.
Authors
Phillip S Ang
1
,
Ekene Ezenwa
2
,
Kichul Ko
3
,
Mark D Hoffman
2
Affiliations
1
Pritzker School of Medicine, The University of Chicago, Chicago, Illinois.
2
Section of Dermatology, Department of Medicine, The University of Chicago Medical Center, Chicago, Illinois.
3
Section of Rheumatology, Department of Medicine, The University of Chicago Medical Center, Chicago, Illinois.
PMID:
38162409
PMCID:
PMC10757231
DOI:
10.1016/j.jdcr.2023.10.023
No abstract available
Keywords:
anifrolumab; antibody; biologic; dermatomyositis; interferon.
Publication types
Case Reports